486 related articles for article (PubMed ID: 15282233)
1. Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?
Di Perri G; Bonora S
J Antimicrob Chemother; 2004 Sep; 54(3):593-602. PubMed ID: 15282233
[TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
4. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs.
Abate G; Miörner H; Ahmed O; Hoffner SE
Int J Tuberc Lung Dis; 1998 Jul; 2(7):580-4. PubMed ID: 9661826
[TBL] [Abstract][Full Text] [Related]
5. Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation.
Abate G
Ethiop Med J; 2002 Jan; 40(1):79-86. PubMed ID: 12240570
[TBL] [Abstract][Full Text] [Related]
6. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
[TBL] [Abstract][Full Text] [Related]
7. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study].
Yoshiyama T; Ogata H; Ito K; Aono A; Wada M
Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318
[TBL] [Abstract][Full Text] [Related]
8. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.
Ahmad S; Mokaddas E
Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of drug resistance in Mycobacterium tuberculosis.
Zhang Y; Yew WW
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
[TBL] [Abstract][Full Text] [Related]
11. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000-2004.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2006 Mar; 55(11):301-5. PubMed ID: 16557213
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand.
Pracharktam R; Angkananukool K; Vibhagool A
J Med Assoc Thai; 2001 Sep; 84(9):1241-5. PubMed ID: 11800295
[TBL] [Abstract][Full Text] [Related]
13. [Surveillance of resistance of Mycobacterium tuberculosis to anti-TB drugs in Cuba, 1995-1998].
Montoro E; Echemendía M; Lemus D; Marrero A; Llanes MJ; Valdivia JA
Biomedica; 2004 Jun; 24 Supp 1():80-4. PubMed ID: 15495575
[TBL] [Abstract][Full Text] [Related]
14. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
[TBL] [Abstract][Full Text] [Related]
15. Drug resistance trends among previously treated tuberculosis patients in a national registry in Peru, 1994-2001.
Vásquez-Campos L; Asencios-Solis L; Leo-Hurtado E; Quispe-Torres N; Salazar-Lindo E; Bayona J; Becerra MC
Int J Tuberc Lung Dis; 2004 Apr; 8(4):465-72. PubMed ID: 15141740
[TBL] [Abstract][Full Text] [Related]
16. Treatment of multidrug-resistant tuberculosis during pregnancy: long-term follow-up of 6 children with intrauterine exposure to second-line agents.
Drobac PC; del Castillo H; Sweetland A; Anca G; Joseph JK; Furin J; Shin S
Clin Infect Dis; 2005 Jun; 40(11):1689-92. PubMed ID: 15889370
[TBL] [Abstract][Full Text] [Related]
17. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
18. The resistance to major antituberculous drugs of Mycobacterium tuberculosis strains isolated from the respiratory system specimens of tuberculosis patients in Duzce, Turkey.
Ozturk CE; Balbay OA; Kaya D; Ceyhan I; Bulut I; Sahin I
Jpn J Infect Dis; 2005 Feb; 58(1):47-9. PubMed ID: 15728994
[TBL] [Abstract][Full Text] [Related]
19. [Process of acquiring drug resistance: retrospective review of records of MDR TB].
Yoshiyama T; Ito K; Ogata H; Mitarai S; Hoshino H; Okumura M; Aman K; Aono A; Wada M
Kekkaku; 2004 Dec; 79(12):717-24. PubMed ID: 15782617
[TBL] [Abstract][Full Text] [Related]
20. Antituberculosis drug resistance in the south of Vietnam: prevalence and trends.
Huong NT; Lan NT; Cobelens FG; Duong BD; Co NV; Bosman MC; Kim SJ; van Soolingen D; Borgdorff MW
J Infect Dis; 2006 Nov; 194(9):1226-32. PubMed ID: 17041848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
